Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells

Gene Therapy

Volumn 9, Issue 14, 2002, Pages 972-979

  Savontaus, M J ^a   Sauter, B V ^a   Huang, T G ^a   Woo, S L C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Anti angiogenesis; Cancer treatment; Gene therapy; Transcriptional targeting

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOGLIN; VASCULOTROPIN RECEPTOR 2; VIRUS PROTEIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CAPILLARY PROLIFERATION; CELL DIVISION; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOTHELIUM CELL; ENHANCER REGION; GENE CONTROL; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TUMOR CELL; UMBILICAL VEIN; VIRUS CULTURE; VIRUS GENE; VIRUS REPLICATION; WILD TYPE;

ADENOVIRIDAE; ANTIGENS, CD; CAPILLARIES; CELL DIVISION; CELL LINE; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENES, REGULATOR; GENETIC ENGINEERING; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0036325057     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301747     Document Type: Article

References (41)

1. Replication-selective adenoviruses as oncolytic agents
2. Replicative adenoviruses for cancer therapy
3. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
4. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors
5. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma
6. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen
7. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts
8. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
9. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
10. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
11. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
12. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial
13. Angiogenesis in cancer, vascular, rheumatoid and other disease
14. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
15. Angiogenesis in cancer and other diseases
16. Mechanisms of angiogenesis
17. Tumor angiogenesis - New drugs on the block
18. Progress in antiangiogenic gene therapy of cancer
19. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
20. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
21. Vascular endothelial growth factor: Molecular and biological aspects
22. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
23. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
24. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences
25. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells
26. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1
27. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
28. Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors
29. Antibody-directed targeting of the vasculature of solid tumors
30. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
31. Adenovirus-mediated cytotoxicity of chronic lymphocytic leukemia cells
32. The TATA homology and the mRNA 5′ untranslated sequence are not required for expression of essential adenovirus E1A functions
33. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1, 4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo
34. Cancer gene therapy: Hard lessons and new courses
35. Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
36. Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment
37. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
38. Alpha v integrins as receptors for tumor targeting by circulating ligands
39. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
40. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter
41. Isolation and characterization of insertion mutants in E1A of adenovirus type 5